CU6 4.30% $7.12 clarity pharmaceuticals ltd

Research/Valuation, page-544

  1. 5,013 Posts.
    lightbulb Created with Sketch. 339

    I'm hoping they'll go it alone on prostate diagnostic.
    TLX has shown it can be done pretty quickly and smoothly.

    $2bUS annual revenue awaits.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.